Oral contraceptive use and the clinical course of Crohn's disease: A prospective cohort study

Gut

Volumn 45, Issue 2, 1999, Pages 218-222

  Cosnes, J ^a   Carbonnel, F ^a   Carrat, F ^b   Beaugerie, L ^a   Gendre, J P ^a  

^a HÔPITAL ROTHSCHILD   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Crohn's disease; Oral contraceptives; Smoking

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; ESTROGEN; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; METHOTREXATE; OLSALAZINE; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE; PROGESTERONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING;

EID: 0032816583     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.2.218     Document Type: Article

References (25)

1. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-54.
2. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992;33:779-82.
3. Duffy LC, Zielezny MA, Marshall JR, et al. Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med 1990;6:161-6.
4. Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990;98:1123-8.
5. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-48.
6. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of smoking on the long term course of Crohn's disease. Gastroenterology 1996;110:424-31.
7. Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;1:1057-62.
8. Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995;108:1011-15.
9. Beller FK, Ebert C. Effects of oral contraceptives on blood coagulation. A review. Obstet Gynecol Surv 1988;40;125-36.
10. Wakefield AJ, Sawyerr AM, Hudson M, et al. Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 1991;36:1147-50.
11. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study. Gastroenterology 1989;97:1442-7.
12. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37;668-73.
13. Katschinski B, Fingerle D, Scherbaum B, et al. Oral contraceptive use and cigarette smoking in Crohn's disease. Dig Dis Sci 1993;38:1596-600.
14. Sandler RS, Wurzelmann JL, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology 1992;3:374-8.
15. Boyko EJ, Theis MK, Vaughan TL, Nicol-Blades B. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol 1994;140:268-78.
16. Wright JP. Factors influencing first relapse in patients with Crohn's disease. J Clin Gastroenterol 1992;15:12-16.
17. Sutherland LR, Ramcharan S, Bryant H, et al. Effect of oral contraceptive use on reoperation following surgery for Crohn's disease. Dig Dis Sci 1992;37:1377-82.
18. Timmer A, Sutherland LR, Martin F, et al. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. Gastroenterology 1998;114:1143-50.
19. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24:2-6.
20. Best WR, Becktel JM, Singleton JW. Rederived values of eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979;77:843-6.
21. Poller L. Oral contraceptives, blood clotting and thrombosis. Br Med Bull 1978;34:151-6.
22. Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140-4.
23. Liebman HA, Kashani N, Sutherland D, et al. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 1998;115:830-4.
24. Petitti DB, Sidney S, Bernstein A, et al. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996;335:8-15.
25. Hennekens CH, MacMahon B. Oral contraceptives and myocardal infarction. N Engl J Med 1997;296:1166-7.